Despite longstanding recognition of IKZF1 as a tumor suppressor in B-ALL, the molecular mechanisms by which IKAROS enforces lineage restriction and constrains leukemic programs in humans have remained incompletely defined. This evidence concerns the gene IKZF1 and acute lymphoblastic leukemia.